Effect of simvastatin in the treatment of highly sensitized dialysis patients: The pre and post-renal transplantation follow-up outcomes

Transplant Immunology

Volumn 13, Issue 1, 2004, Pages 39-42

  Nurhan Ozdemir, Fatma ^a   Akcay, Ali ^a,b   Sezer, Siren ^a   Arat, Zubeyde ^a   Colak, Turan ^a   Turan, Munire ^a   Gulmus, Sale ^a   Haberal, Mehmet ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

End stage renal failure; HLA sensitization; Panel reactive antibody; Renal transplantation; Simvastatin

Indexed keywords

SIMVASTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIALYSIS; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HEPATITIS; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

ADULT; B-LYMPHOCYTES; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; KIDNEY TRANSPLANTATION; MALE; RENAL DIALYSIS; SIMVASTATIN; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 2942615371     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.03.002     Document Type: Article

References (15)

1. Abe M., Kawai T., Futatsuyama T., et al. Postoperative production of anti-donor antibody and chronic rejection in renal transplantation. Transplantation. 63:1997;1616-1619
2. Barama A., Oza U., Panek R., et al. Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living-related kidney transplants. Clin Transplant. 14:2000;212-217
3. Sumitran-Holgersson S. HLA-specific alloantibodies and renal graft outcome. Nephrol Dial Transplant. 16:2001;897-904
4. Matas A.J., Gillingham K., Payne W.D., et al. Should I accept this kidney? Clin Transplant. 14:2000;90-95
5. Monteiro F., Buelow R., Mineiro C., Rodrigues H., Kalil J. Identification of patients at high risk of graft loss by pre- and post-transplant monitoring of anti-HLA class I IgG antibodies by enzyme-linked immunosorbent assay. Transplantation. 63:1997;542-546
6. Glotz D., Haymann J.P., Niaudet P., Lang P., Druet P., Bariety J. Successful kidney transplantation of immunized patients after desensitization with normal human polyclonal immunoglobulins. Transplant Proc. 27:1995;1038-1039
7. Hiesse C., Kriaa F., Rousseau P., et al. Immunoadsorption of anti-HLA antibodies for highly sensitized patients awaiting renal transplantation. Nephrol Dial Transplant. 7:1992;944-951
8. Ozdemir F.N., Sezer S., Turan M., Colak T., Arat Z., Gulmus S., Haberal M. The effect of simvastatin on panel-reactive antibody and cross-match positivity. Transplant Proc. 33:2001;2842-2843
9. Fellstrom B. Impact and management of hyperlipidemia posttransplantation. Transplantation. 70:(11 Suppl):2000;1-7
10. Katznelson S., Wang X.M., Chia D., et al. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro. J Heart Lung Transplant. 17:1998;335-340
11. Rudich S.M., Mongini P.K., Perez R.V., Katznelson S. HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation. Transplant Proc. 30:1998;992-995
12. Katznelson S., Ramirez A., Perez R., Weiss R. Pravastatin and cyclosporine inhibit platelet-derived growth factor-stimulated vascular smooth muscle cell mitogenesis: an investigation of mechanisms. Transplant Proc. 30:1998;998-999
13. Katznelson S. Effect of HMG-CoA reductase inhibitors on chronic allograft rejection. Kidney Int. 71:(Suppl):1999;117-121
14. Katznelson S., Wilkinson A.H., Kobashigawa J.A., et al. The effect of pravastatin on acute rejection after kidney transplantation - a pilot study. Transplantation. 61:1996;1469-1474
15. Katznelson S., Kobashigawa J.A. Dual roles of HMG-CoA reductase inhibitors in solid organ transplantation: lipid lowering and immunosuppression. Kidney Int. 52:(Suppl):1995;112-115